# Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)

> **NCT00757627** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 500 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** etoricoxib

## Key facts

- **NCT ID:** NCT00757627
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00757627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00757627, "Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00757627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*